126 related articles for article (PubMed ID: 18347138)
21. Nitric oxide-donating derivatives of hederacolchiside A
Fang Y; Wang R; He M; Huang H; Wang Q; Yang Z; Li Y; Yang S; Jin Y
Bioorg Med Chem Lett; 2017 Jan; 27(1):98-101. PubMed ID: 27866816
[TBL] [Abstract][Full Text] [Related]
22. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
23. Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells.
Deng L; Zhang E; Chen C
Arch Pharm Res; 2013 May; 36(5):619-25. PubMed ID: 23494564
[TBL] [Abstract][Full Text] [Related]
24. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
Pini A; Viappiani S; Bolla M; Masini E; Bani D
J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
[TBL] [Abstract][Full Text] [Related]
25. VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus.
Fagone P; Muthumani K; Mangano K; Magro G; Meroni PL; Kim JJ; Sardesai NY; Weiner DB; Nicoletti F
Immunology; 2014 Aug; 142(4):594-602. PubMed ID: 24527796
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect.
Kashfi K; Rayyan Y; Qiao LL; Williams JL; Chen J; Del Soldato P; Traganos F; Rigas B; Ryann Y
J Pharmacol Exp Ther; 2002 Dec; 303(3):1273-82. PubMed ID: 12438552
[TBL] [Abstract][Full Text] [Related]
27. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines.
Mimeault M; Jouy N; Depreux P; Hénichart JP
Prostate; 2005 Feb; 62(2):187-99. PubMed ID: 15389789
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines.
Huguenin S; Vacherot F; Fleury-Feith J; Riffaud JP; Chopin DK; Bolla M; Jaurand MC
Cancer Lett; 2005 Feb; 218(2):163-70. PubMed ID: 15670893
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma.
Perrotta C; Bizzozero L; Falcone S; Rovere-Querini P; Prinetti A; Schuchman EH; Sonnino S; Manfredi AA; Clementi E
Cancer Res; 2007 Aug; 67(16):7559-64. PubMed ID: 17699758
[TBL] [Abstract][Full Text] [Related]
31. Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs.
Bonavida B
Biochem Pharmacol; 2020 Jun; 176():113913. PubMed ID: 32173364
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
[TBL] [Abstract][Full Text] [Related]
33. Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin.
Hulsman N; Medema JP; Bos C; Jongejan A; Leurs R; Smit MJ; de Esch IJ; Richel D; Wijtmans M
J Med Chem; 2007 May; 50(10):2424-31. PubMed ID: 17441704
[TBL] [Abstract][Full Text] [Related]
34. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.
Vucicevic L; Misirkic M; Janjetovic K; Vilimanovich U; Sudar E; Isenovic E; Prica M; Harhaji-Trajkovic L; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V
Autophagy; 2011 Jan; 7(1):40-50. PubMed ID: 20980833
[TBL] [Abstract][Full Text] [Related]
35. A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro.
Fuggetta MP; Spanu P; Ulgheri F; Deligia F; Carta P; Mannu A; Trotta V; De Cicco R; Barra A; Zona E; Morelli F
Anticancer Agents Med Chem; 2019; 19(4):567-578. PubMed ID: 30706794
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells.
Donia M; Maksimovic-Ivanic D; Mijatovic S; Mojic M; Miljkovic D; Timotijevic G; Fagone P; Caponnetto S; Al-Abed Y; McCubrey J; Stosic-Grujicic S; Nicoletti F
Cell Cycle; 2011 Feb; 10(3):492-9. PubMed ID: 21270522
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells.
Rajendra Prasad VV; Deepak Reddy G; Kathmann I; Amareswararao M; Peters GJ
Bioorg Chem; 2016 Feb; 64():51-8. PubMed ID: 26657603
[TBL] [Abstract][Full Text] [Related]
39. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
40. [Advances in the study of nitric oxide-donating drugs].
Zhang YH; Peng SX
Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]